Alkem Labs to grow chronic therapies to drive future growth: MD

The Mumbai-based drug maker, which entered the US generics market over a decade ago, is also scaling back its investments in oral solids in the face of competition and price erosion.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ys1WvzK
via IFTTT